Jim Zarroli

Jim Zarroli is a business reporter for NPR News, based at NPR's New York bureau.

He covers economics and business news including fiscal policy, the Federal Reserve, the job market and taxes

Over the years, he's reported on recessions and booms, crashes and rallies, and a long string of tax dodgers, insider traders and Ponzi schemers. He's been heavily involved in the coverage of the European debt crisis and the bank bailouts in the United States.

Prior to moving into his current role, Zarroli served as a New York-based general assignment reporter for NPR News. While in this position he covered the United Nations during the first Gulf War. Zarroli added to NPR's coverage of the aftermath of Hurricane Katrina, the London transit bombings and the September 11, 2001 attacks on the World Trade Center.

Before joining the NPR in 1996, Zarroli worked for the Pittsburgh Press and wrote for various print publications.

Zarroli graduated from Pennsylvania State University.

Pages

Asia
2:37 am
Thu April 24, 2014

After Bangladesh Factory Disaster, Efforts Show Mixed Progress

Garment workers and relatives of Rana Plaza victims stage a demonstration on the outskirts of Dhaka, Bangladesh, Dec. 24.
Shariful Islam Xinhua/Landov

Originally published on Thu April 24, 2014 6:30 am

One year ago Thursday, an eight-story factory building in the Bangladesh capital of Dhaka collapsed, killing more than 1,100 workers. The disaster at Rana Plaza brought new attention to safety conditions in the country's booming garment industry.

In the year since then, some of the world's biggest retailers have begun inspecting Bangladesh's factories more aggressively. But in other ways efforts to reform the industry have fallen short.

Read more
Business
3:09 pm
Wed April 23, 2014

Blockbuster Trades Are Changing The Face Of Pharmaceuticals

Originally published on Wed April 23, 2014 10:06 pm

Transcript

MELISSA BLOCK, HOST:

The pharmaceutical industry is undergoing some sweeping changes so the past few days, some major deals have been announced. The first involving a trio of big named companies: GlaxoSmithKline, Novartis and Ely Lily. The second is a proposed deal between Quebec-based Valeant Pharmaceuticals and California's Allergan, the maker of Botox. That deal is valued at $45 billion. NPR's Jim Zarroli reports.

Read more
Business
5:23 am
Fri April 18, 2014

IPO Market Shows Signs Of Strain

Originally published on Fri April 18, 2014 10:10 am

Transcript

DAVID GREENE, HOST:

All right, Virtu Financial has reportedly decided to postpone its initial public offering. The decision comes during a week when several IPOs in U.S. markets had disappointing debuts. Virtu conducts high-frequency electronic trading on various exchanges and scrutiny of high-speed trading is growing.

NPR's Jim Zarroli reports.

Read more
Economy
4:29 pm
Tue April 15, 2014

Sending Money On An Overseas Round Trip To Avoid Taxes

Round-tripping occurs when American citizens open bank accounts in tax havens such as the Cayman Islands, funnel money into the accounts and then use it to buy stocks and bonds back in the U.S.
David McFadden AP

Originally published on Tue April 15, 2014 5:03 pm

Some investors avoid paying taxes in a move called round-tripping — sending money offshore, then investing it in U.S. stocks or bonds. A study estimates it costs the U.S. billions in lost revenues.

Recently, MIT professor Michelle Hanlon and two colleagues set out to find out all they could about round-tripping.

Read more
News
3:08 pm
Wed April 9, 2014

With Proposed Mega-Merger On The Hill, Spotlight's On Consumers

Originally published on Wed April 9, 2014 5:48 pm

Comcast and Time Warner executives ran into stiff opposition as they pitched their proposed merger to the Senate Judiciary Committee. The deal would give the combined company a large share of both pay TV and broadband internet service markets. In both cases, lawmakers wanted to know how consumers would be affected.

Pages